1 / 1

DNA/Ad5

HIV Prevention Options Timeline * **. AVAC, December 2012. Bangkok Tenofovir Study/CDC 4370. 2005. Oral TDF. TIMELINE LEGEND. Oral TDF. Partners PrEP. Partners PrEP (no placebo). 2008. Oral TDF/FTC. Positive efficacy result. TFV gel. VOICE/MTN 003. 2009. Arm stopped.

oakley
Télécharger la présentation

DNA/Ad5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV Prevention Options Timeline *** AVAC, December 2012 Bangkok Tenofovir Study/CDC 4370 2005 Oral TDF TIMELINE LEGEND Oral TDF Partners PrEP Partners PrEP (no placebo) 2008 Oral TDF/FTC Positive efficacy result TFV gel VOICE/MTN 003 2009 Arm stopped Rectal TFV gel Regulatory submission/filing Oral TDF/FTC TDF2/CDC 4940 TDF2 Open-Label Extension DPV ring 2007 TMC278 LA Injectable iPrEx iPrEx Open-Label Extension (OLE) 2007 Planned FEM-PrEP DNA/Ad5 2009 Final results pending Additional demonstration projects & intermittent PrEP studies Pox-Protein US FDA approval CAPRISA 004 2007 TFV gel CAPRISA 008 VOICE/MTN 003 Earliest regulatory submission 2009 FACTS 001 Rectal TFV gel FACTS 002 and other adolescent studies DPV Ring MTN 017 Earliest regulatory submission ASPIRE/MTN 020 TMC 278 LA Inject. The Ring Study/IPM 027 Possible TMC278 LA Injectable DNA/Ad5 HVTN 505 2009 South Africa Licensure RV 144 2004 Pox-Protein South Africa Research Various Phase I/II preliminary and bridging studies Thai Licensure * Trial end-dates are estimates; due to the nature of clinical trials the actual dates may change. For full trial details, see www.avac.org/pxrd. ** Not all trials included are effectiveness trials. Trials included on this list are mainly phase II/IIb, III/IIIb and IV trials.

More Related